Heart Failure With Preserved Ejection Fraction trials recruiting in Texas

All Heart Failure With Preserved Ejection Fraction trials nationally

Cities in Texas

Recruiting trials in Texas

• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, Fort Worth, Houston
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Conroe, Dallas
• Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction
  NCT06061549 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · Texas: Dallas
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
  NCT05838287 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
  NCT05057806 · Phase: Early Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · Texas: Dallas, Miami, San Antonio
• Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF
  NCT05723679 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 90 Years · Sex: All (male and female) · Texas: Dallas